Jazz Pharmaceuticals Other Non-Current Liabilities 2010-2024 | JAZZ
Jazz Pharmaceuticals other non-current liabilities for the quarter ending September 30, 2024 were $0.111B, a 12.95% decline year-over-year.
- Jazz Pharmaceuticals other non-current liabilities for 2023 were $0.105B, a 1.93% decline from 2022.
- Jazz Pharmaceuticals other non-current liabilities for 2022 were $0.107B, a 8.71% decline from 2021.
- Jazz Pharmaceuticals other non-current liabilities for 2021 were $0.117B, a 15.67% increase from 2020.